Kostiukova, N.I., L.Ye. Fishchuk, Z.I. Rossokha, N.L. Medvedieva, S.V. Andreieva, S.V. Bloshchinska, O.F. Popova, S.V. Vydyborets, and N.G. Gorovenko. “CYP2C19*2 Gene Variant (G681A, rs4244285) As a Prognostic Marker for the Clinical Course of Multiple Myeloma”. Experimental Oncology 43, no. 4 (May 26, 2023): 336–340. Accessed November 26, 2025. https://exp-oncology.com.ua/index.php/Exp/article/view/2021-4-7.